71.2 lbs on average) Retatrutide 9mg: 26.4% body weight reduction Tirzepatide/Zepbound (Phase 3 comparison, not head-to-head): ~20.9% Semaglutide/Wegovy (Phase 3 comparison, not head-to-head): ~14.9% Placebo: ~2.1% Note: These figures come from separate Phase 3 trials and are not direct head-to-head comparisons
Studies typically show improvements in fasting glucose, HbA1c, and HOMA-IR (a measure of insulin resistance) after 12-24 weeks of treatment
Regulates Insulin and Blood Sugar By helping regulate insulin and blood sugar levels, semaglutide can improve control over caloric intake, as insulin plays a role in how the body uses and stores energy
In other words, the mechanism makes microdosing biologically plausible, but reliable outcomes remain tied to dose levels that have been studied
With a growing range of products, exceptional pricing, and good customer service, they are a force to be reconned with